Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 4,015.00
-205.00 (-4.86%)
At close: Oct 22, 2026
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 209.98 billion as of October 22, 2026. It is the 21,836th most valuable company in the world and the 779th biggest in South Korea. Its market cap has increased by 148.80% in one year.
Market Cap
209.98B
Enterprise Value
184.71B
Revenue
24.46B
Global Rank
Country Rank
#779 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 209.98B, an increase of 192.14%. That is a compound annual growth rate of 14.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 209.98B | -11.91% |
| Dec 30, 2025 | 238.38B | 179.77% |
| Dec 30, 2024 | 85.21B | -51.64% |
| Dec 28, 2023 | 176.21B | -28.34% |
| Dec 29, 2022 | 245.90B | -47.55% |
| Dec 30, 2021 | 468.83B | -55.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 348.66B |
| HansBiomed | 264.98B |
| S.Biomedics | 262.56B |
| IntoCell | 249.51B |
| IMBiologics | 221.06B |
| curacle co.,ltd. | 201.63B |
| Kangstem Biotech | 184.91B |
| NIBEC | 177.46B |